Seeing Is Believing
Currently out of the existing stock ratings of William Pickering, 27 are a HOLD (39.71%), 36 are a BUY (52.94%), 5 are a SELL (7.35%).
Analyst William Pickering, currently employed at BERNSTEIN, carries an average stock price target met ratio of 75.17% that have a potential upside of 15.67% achieved within 125 days.
William Pickering’s has documented 136 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on REGN, Regeneron Pharmaceuticals at 17-May-2026.
Analyst best performing recommendations are on CRSP (CRISPR THERAPEUTICS AG).
The best stock recommendation documented was for ALNY (ALNYLAM PHARMACEUTICALS) at 7/30/2025. The price target of $389 was fulfilled within 1 day with a profit of $49.2 (14.48%) receiving and performance score of 144.79.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Apr-2026
$6
$4.5 (300.00%)
1 months 20 days ago
(17-Aug-2026)
1/11 (9.09%)
$3.92 (188.46%)
148
Buy Since 15-Apr-2026
$10
$8.5 (566.67%)
$10
5 months 15 days ago
(22-Apr-2026)
0/2 (0%)
$7.61 (318.41%)
Buy Since 04-Apr-2023
$11
$8.87 (416.43%)
$12
5 months 21 days ago
(16-Apr-2026)
0/12 (0%)
$8.63 (364.14%)
Sell Since 16-Apr-2026
5 months 21 days ago
(16-Apr-2026)
0/3 (0%)
$2.86 (55.64%)
Hold Since 21-Mar-2023
$3.85
$1.72 (80.75%)
$2.5
5 months 23 days ago
(14-Apr-2026)
2/3 (66.67%)
$1.13 (41.54%)
155
Which stock is William Pickering most bullish on?
Which stock is William Pickering most reserved on?
What Year was the first public recommendation made by William Pickering?